Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

US Patent 10260084 · Granted Apr 16, 2019

Estimated economic value: $89,036,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cellular glycosaminoglycan compositions and methods of making and using2023
Organophosphate derivatives2022
Nanoparticle compositions2022
Compositions for the treatment of autodigestion2021
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Detection of oligosaccharides2020
Detection of oligosaccharides2020
Detection of oligosaccharides2020